Does SummaCare Cover Propecia?

How SummaCare Formularies Handle Hair-Loss Drugs

Most SummaCare plans treat androgenetic alopecia (pattern hair loss) medications as cosmetic, placing them outside standard prescription coverage. This classification applies to brand-name Propecia and, in many plan designs, to generic finasteride 1 mg as well.

SummaCare, a regional health plan headquartered in Akron, Ohio, maintains separate formularies for its HMO, PPO, and Medicare Advantage products. Each formulary uses a tier system, typically four to five tiers, where Tier 1 covers preferred generics at the lowest copay and Tier 4 or 5 covers specialty or non-preferred brands at the highest out-of-pocket cost. Brand-name Propecia, when listed at all, lands on Tier 3 or higher. Generic finasteride 1 mg occasionally appears on Tier 2, but only when the plan does not apply a blanket cosmetic exclusion to hair-loss indications.

The distinction between finasteride 1 mg and finasteride 5 mg matters here. Finasteride 5 mg (originally marketed as Proscar) carries an FDA-approved indication for benign prostatic hyperplasia (BPH) [2]. Because BPH is a medical condition rather than a cosmetic concern, SummaCare plans routinely cover the 5 mg formulation at preferred generic copay levels. The 1 mg dose, approved exclusively for male pattern hair loss, receives different treatment under most benefit designs.

To verify your specific coverage, log into the SummaCare member portal or call Member Services. Request a formulary exception if your plan excludes finasteride 1 mg, as some exceptions are granted when a prescriber documents medical necessity beyond cosmetic concern, such as documented psychological distress related to hair loss [3].

What Propecia (Finasteride 1 mg) Actually Does

Finasteride is a 5-alpha reductase inhibitor that blocks the conversion of testosterone to dihydrotestosterone (DHT). DHT is the primary androgen responsible for miniaturizing hair follicles in genetically susceptible men.

The original registration trial for Propecia enrolled 1,553 men aged 18 to 41 with mild to moderate vertex hair loss. At 24 months, 83% of men taking finasteride 1 mg daily maintained or increased hair count compared to 28% on placebo [4]. A separate 2012 Cochrane systematic review pooling 12 randomized controlled trials (N=3,927) confirmed that finasteride significantly increases total hair count and improves patient-assessed outcomes relative to placebo, with a number needed to treat of approximately 4 for visible improvement at 12 months [1].

The drug works slowly. Measurable changes in hair count typically appear at 3 to 6 months, with full results visible at 12 months. Discontinuation reverses gains within 6 to 12 months, which means ongoing prescriptions are necessary and cost becomes a long-term consideration rather than a one-time decision.

Side effects occur in a minority of users. The FDA label reports erectile dysfunction in 1.3% of finasteride users versus 0.7% on placebo, decreased libido in 1.8% versus 1.3%, and ejaculation disorder in 1.2% versus 0.7% [5]. These differences are statistically significant but clinically small. Post-marketing reports of persistent sexual side effects after discontinuation (sometimes called "post-finasteride syndrome") have been documented in case series, though large pharmacovigilance studies have not confirmed a causal mechanism [6].

The Cost of Propecia and Finasteride Without SummaCare Coverage

If your SummaCare plan does not cover Propecia or generic finasteride 1 mg, cash pricing is often manageable compared to other prescription medications.

Brand-name Propecia carries a retail price of roughly $90 to $120 for a 30-day supply at Ohio pharmacies. This price has remained relatively stable since Merck's patent expiration in 2013, as the company maintains the brand for patients who specifically request it. Generic finasteride 1 mg, by contrast, costs between $4 and $30 for a 30-day supply depending on the pharmacy. Several large pharmacy chains include generic finasteride on their $4 generic lists, making it one of the least expensive prescription medications available regardless of insurance status.

Pharmacy discount programs like GoodRx, RxSaver, and manufacturer coupons can push the generic price below $10 per month at pharmacies across SummaCare's Ohio service area. At these prices, the cost of filing an insurance claim may exceed the copay benefit, which is one reason many men with insurance still pay cash for finasteride.

For the 5 mg tablet (Proscar), some prescribers write a prescription with instructions to cut the tablet into quarters, yielding approximately 1.25 mg doses at the BPH-indication price. This practice is off-label for hair loss. Insurance plans including SummaCare are more likely to cover the 5 mg tablet because of its BPH indication, but using it for an unapproved indication introduces formulary audit risk and may result in a claim denial if the diagnosis code submitted is for alopecia rather than BPH [7].

Prior Authorization and Step Therapy Requirements

Even when a SummaCare formulary lists finasteride 1 mg, access may require prior authorization (PA) or step therapy.

Prior authorization for hair-loss medications typically requires the prescriber to submit documentation showing the patient has androgenetic alopecia (ICD-10 code L64.9 for alopecia, unspecified, or L64.0 for drug-induced alopecia if relevant). The prescriber may also need to attest that the patient has tried topical minoxidil for at least 6 months without adequate response. This step-therapy requirement reflects clinical guidelines from the American Academy of Dermatology (AAD), which list both minoxidil and finasteride as first-line options for androgenetic alopecia but note that many insurers require sequential therapy [8].

The PA turnaround at SummaCare is typically 48 to 72 hours for standard requests and 24 hours for urgent requests. If denied, the prescriber can file a peer-to-peer appeal. Approval rates for finasteride PAs vary by plan year and are not publicly reported by SummaCare.

One practical detail: if your SummaCare plan uses Express Scripts, CVS Caremark, or OptumRx as its pharmacy benefit manager (PBM), the PA criteria may differ from SummaCare's own medical policy. Ask your pharmacist which PBM processes your drug claims, then contact that PBM directly for the most accurate PA criteria.

SummaCare Medicare Advantage and Finasteride

Medicare Part D, which SummaCare Medicare Advantage plans incorporate, has historically excluded coverage for hair-loss drugs. The Social Security Act Section 1860D-2(e)(2)(A) specifically lists drugs "used for cosmetic purposes or hair growth" among the categories that Part D plans may exclude [9].

This means SummaCare Medicare Advantage members should not expect finasteride 1 mg coverage under their Part D drug benefit. The 5 mg formulation for BPH remains covered under Part D because it treats a medical condition.

For Medicare Advantage members prescribed finasteride 1 mg off-formulary, the out-of-pocket price for generic finasteride remains low enough that lack of Part D coverage is unlikely to create a significant financial barrier. The $4 to $15 monthly cost falls below most Part D copays for Tier 1 generics anyway.

Alternatives if SummaCare Denies Coverage

Several evidence-based alternatives exist if finasteride is not covered or not appropriate for your situation.

Topical minoxidil (Rogaine and generics) is available over the counter without a prescription. A meta-analysis of 7 randomized trials (N=1,920) found that minoxidil 5% solution increased total hair count by a mean of 18.6 hairs per cm² compared to placebo at 48 weeks [10]. Topical minoxidil does not require insurance coverage and costs $15 to $40 per month depending on the formulation and brand.

Oral minoxidil at low dose (off-label, typically 2.5 mg daily) has gained clinical traction after a 2022 systematic review in the Journal of the American Academy of Dermatology showed dose-dependent hair regrowth with a favorable safety profile at doses below 5 mg [11]. Because oral minoxidil at higher doses is FDA-approved for hypertension, generic tablets are widely covered by insurance plans including SummaCare. A prescriber writing oral minoxidil 2.5 mg for hair loss would submit it under the hypertension indication, though this raises the same off-label coding considerations discussed above.

Dutasteride 0.5 mg (Avodart) inhibits both type I and type II 5-alpha reductase, producing greater DHT suppression than finasteride. A phase III trial (N=917) found dutasteride 0.5 mg superior to finasteride 1 mg for change in target-area hair count at 24 weeks [12]. Dutasteride is FDA-approved only for BPH in the United States, so its use for hair loss is off-label. Generic dutasteride costs $10 to $25 per month.

Combination therapy using both minoxidil and finasteride produces additive benefits. The AAD guidelines note that combination therapy may be appropriate for men who have not responded adequately to monotherapy [8].

How to Check Your Specific SummaCare Plan

The only definitive way to know whether your SummaCare plan covers Propecia or generic finasteride is to check your plan documents directly. Three approaches work.

First, log into the SummaCare member portal at summacare.com. Manage to the prescription drug section and search for "finasteride" in the formulary lookup tool. This will show the tier placement, any PA requirements, and quantity limits for your specific plan. Second, call SummaCare Member Services at the phone number printed on the back of your insurance card. Ask specifically: "Is finasteride 1 mg covered under my pharmacy benefit for the diagnosis of androgenetic alopecia?" The diagnosis specification matters because the same drug may be covered for BPH but excluded for hair loss. Third, ask your pharmacist to run a test claim. This produces a real-time adjudication that shows whether the claim would be approved, denied, or pended for PA.

If your plan excludes finasteride 1 mg entirely, consider whether the $4 to $15 monthly cash price for generic finasteride makes insurance coverage a non-issue. For many SummaCare members in Ohio, the cash price is competitive with or lower than a Tier 1 copay.

Clinical Expectations and Monitoring

Men starting finasteride should understand realistic timelines and monitoring needs regardless of how they pay for the medication.

Baseline photography using standardized scalp positioning helps track response objectively. The Norwood-Hamilton scale classifies male pattern baldness from Type I (minimal recession) through Type VII (extensive loss), and finasteride performs best in Types II through V [4]. Men with Type VI or VII loss are unlikely to see cosmetically meaningful regrowth, though the drug may slow further progression.

Blood work is not routinely required before starting finasteride 1 mg. The AAD does not recommend baseline hormone panels for otherwise healthy men beginning finasteride for hair loss [8]. One clinical note: finasteride reduces serum PSA levels by approximately 50%. Men undergoing prostate cancer screening should inform their urologist that they take finasteride so the PSA value can be adjusted accordingly. The FDA label includes this warning explicitly [5].

Follow-up assessment at 6 and 12 months determines whether the medication is working. If no improvement is visible at 12 months with consistent daily use, continuing the medication for hair regrowth (as opposed to maintenance) is unlikely to yield additional benefit based on the original trial kinetics [4]. Maintenance of existing hair, however, may still justify continued use even without visible regrowth. In the 5-year extension of the key trial, 90% of men on continuous finasteride maintained their hair count above baseline compared to progressive loss in the placebo-crossover group [13].